Medical Device and Diagnostic Industry (MD+DI)

FDA Approves Johnson & Johnson's Breakthrough Cataracts Solution

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Are you about to have cataract surgery? Here’s what ophthalmologists say you need to know

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...
Healio

Successful cataract surgery can follow removal of posterior chamber phakic IOL

Please provide your email address to receive an email when new articles are posted on . Phakic lens implants are useful for the treatment of high degrees of myopia, which are beyond the capabilities ...
Ophthalmology Times

FDA approves Johnson & Johnson's TECNIS PureSee EDOF IOL

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Medscape

Cataract Surgery May Help Prevent Falls and Fractures

Cataract extraction with intraocular lens insertion (CEIOL) was associated with reduced odds of falls, fractures, and intracranial hemorrhage in adults aged 60 years or older. Researchers conducted a ...
Becker's ASC

Payment Policy for an A-C IOL Inserted Following Removal of a Cataract in Surgery Centers

The following Q&A comes from the Centers for Medicare & Medicaid Services website. Q: What is the payment policy for an Astigmatism-Correcting Intraocular Lens (A-C IOL) inserted following removal of ...
PharmiWeb

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...